Business

MannKind Corporation, which is waiting for FDA approval of its Afrezza inhaled insulin, announced that it hopes to raise up to $110 million by lending 9 million shares of its stock to Bank of America. Merrill Lynch will then sell the borrowed shares, shorting the stock, and will use the proceeds in conjunction with a private offering of MannKind Senior Convertible … [Read more...] about MannKind announces $110 million stock agreement

Cannabis Science and Smokefree Innotec will co-develop pharmaceutical cannabis products for inhalation. Smokefree Innotec, which manufactures electronic cigarettes, will develop the devices, with Cannabis Science developing the formulations. Read the company's press release … [Read more...] about Cannabis Science and Smokefree Innotec sign development agreement

RTS Life Sciences has formed RTL Life Science LLC, based near Boston, MA.  RTS manufactures automated inhaler testing systems. Read the company's press release. … [Read more...] about RTS announces new US Headquarters

Vectura will license dry powder formulation technology to GlaxoSmithKline for use in respiratory products for up to £20 million. The deal is for worldwide rights and is non-exclusive. Read the company's press release. … [Read more...] about GSK licenses DPI formulation technology from Vectura